HOW FDA EXPANDS RECALL ON BLOOD PRESSURE MEDICATION: LOSARTAN!

For Immediate Release From The Food and Drug Administration!


The Food and Drug Administration is again expanding its recall of widely prescribed blood pressure drugs due to contamination (https://www.nbcnews.com/health/health-news/fda-once-again-expands-recall-blood-pressure-drugs-n1023446) with a cancer-linked chemical.

Monday's announcement (https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/updated-torrent-pharmaceuticals-limited-expands-voluntary-nationwide-recall-losartan-potassium-0) targets an additional five lots of the generic drug losartan made by Torrent Pharmaceuticals Limited. The lots include losartan potassium (https://www.walmart.com/search/?query=potassium&irgwc=1&sourceid=imp_ShfVx1V7VxyJTRVwUx0Mo3YRUknx0oXuNWnP0o0&veh=aff&wmlspartner=imp_27795&clickid=ShfVx1V7VxyJTRVwUx0Mo3YRUknx0oXuNWnP0o0) tablets and losartan potassium/hydrochlorothiazide tablets.

The recalled lots contain trace amounts of N-methylnitrosobutyric acid, or NMBA, which has been linked to cancer.

Read the full article HERE!: https://www.msn.com/en-us/health/health-ne...